Literature DB >> 16307954

In-house trauma attendings: is there a difference?

Rodney Durham1, David Shapiro, Lewis Flint.   

Abstract

INTRODUCTION: Outcomes of patients who met trauma activation criteria were examined before and after implementation of in-house attending call.
MATERIALS AND METHODS: Outcomes for the out-of-house period (OH) (February 1, 2001 to October 31, 2002) were compared with the in-house period (IH) (November 1, 2002 to June 30, 2004). Measures included overall mortality, length of stay (LOS) in the hospital, intensive care unit (ICU) and emergency department, and preventable deaths.
RESULTS: A total of 2,019 trauma activations were studied (1,036 OH, 983 IH). The groups were equivalent on admission. There was no difference in hospital LOS, ICU LOS, ventilator days, or overall mortality. Preventable deaths occurred in 8.1% of the OH group and in 1.0% of the IH group (P < .02).
CONCLUSIONS: Aggregate statistics and the use of surrogate markers to determine outcomes may not accurately portray the impact of attending surgeons on the quality of care. Implementation of in-house call resulted in a decreased incidence of preventable deaths.

Entities:  

Mesh:

Year:  2005        PMID: 16307954     DOI: 10.1016/j.amjsurg.2005.08.028

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

Review 1.  Critical care issues in the early management of severe trauma.

Authors:  Alberto Garcia
Journal:  Surg Clin North Am       Date:  2006-12       Impact factor: 2.741

2.  The Respiratory Rate: A Neglected Triage Tool for Pre-hospital Identification of Trauma Patients.

Authors:  John D Yonge; Phillip Kemp Bohan; Justin J Watson; Christopher R Connelly; Lynn Eastes; Martin A Schreiber
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

3.  The effect of an on-site trauma surgeon during resuscitations of severely injured patients.

Authors:  Oscar E C van Maarseveen; Wietske H W Ham; Loek P H Leenen
Journal:  BMC Emerg Med       Date:  2022-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.